Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Ibuprofen impurity 11 is a known impurity associated with the analgesic and anti-inflammatory drug ibuprofen. This compound is utilized primarily in research to assess the purity of ibuprofen formulations and to study the potential effects of drug impurities on efficacy and safety. Its presence and quantification play a crucial role in pharmaceutical development and quality control processes. -
Drug Impurity
Quetiapine impurity 24 is a chemical impurity associated with the antipsychotic agent Quetiapine. It serves as a critical analytical reference standard for assessing the purity and quality of Quetiapine in pharmaceutical formulations. This reagent is essential for researchers conducting stability and degradation studies, ensuring compliance with regulatory standards in drug development and quality control. -
Drug Impurity
Simvastatin impurity 14 is a known impurity of Simvastatin, primarily utilized in the evaluation of pharmaceutical formulations. It aids in the assessment of drug purity and quality control processes within the pharmaceutical industry. This impurity can serve as a reference standard in analytical studies to ensure compliance with regulatory specifications and to support the development of high-quality therapeutic agents. -
Drug Impurity
Telmisartan impurity 16 is a drug impurity associated with Telmisartan, an angiotensin II receptor antagonist used primarily for the treatment of hypertension. The presence of this impurity is significant for the characterization and quality control of pharmaceutical formulations. This compound can be employed in research to study the effects of drug impurities on pharmacokinetics and pharmacodynamics, as well as their potential implications in drug safety and efficacy. -
Drug Impurity
Aripiprazole impurity 17 is a known impurity of the antipsychotic agent Aripiprazole. This chemical reagent is crucial for analytical studies involving drug formulation and quality control. Its characterization plays a significant role in pharmaceutical research, particularly in the assessment of the quality and safety of Aripiprazole preparations. -
Drug Impurity
Simvastatin impurity 13 is a characterized impurity associated with Simvastatin, a competitive inhibitor of HMG-CoA reductase. This compound is significant for quality control and compliance in the synthesis of Simvastatin, ensuring the integrity and safety of the final pharmaceutical product. It is suitable for use in analytical studies and regulatory assessments related to drug purity and formulation. -
Drug Impurity
Metoprolol impurity 2 is a known impurity of the beta-adrenergic blocker metoprolol. This compound is primarily utilized in pharmaceutical development and quality control to assess the purity of metoprolol formulations. Its presence can be critical for understanding the metabolic pathways and potential effects of metoprolol in drug applications. -
Drug Impurity
Cinacalcet impurity 7 is a known impurity of the calcimimetic agent cinacalcet. As a drug impurity, it serves as an important analytical reference for the characterization and quality control of cinacalcet formulations. Its presence can influence the pharmacological profiles of the primary compound, making it essential for study in formulation development and regulatory assessments in pharmaceutical research. -
Drug Impurity
Nintedanib impurity 5 is a synthetic impurity associated with the pharmacological compound Nintedanib. This impurity is primarily utilized in analytical and quality control settings within pharmaceutical research to ensure the purity and consistency of Nintedanib formulations. Its detection and characterization are crucial for regulatory compliance and improving the safety profile of Nintedanib in therapeutic applications. -
Drug Impurity
Solifenacin impurity 7, also known as Solifenacin impurity B, is a chemical byproduct associated with the synthesis of Solifenacin. This impurity serves as a critical compound for quality control assessments in pharmaceutical research, particularly in the development and validation of analytical methods. Its characterization is essential for understanding the stability, safety, and efficacy profiles of Solifenacin formulations. -
Drug Impurity
Fluphenazine decanoate hydrochloride is a drug impurity associated with the antipsychotic agent fluphenazine. This compound may arise during the synthesis of fluphenazine formulations and can potentially affect the stability and efficacy of the final product. It is primarily utilized in research to study its impact on pharmacological profiles and to ensure quality control in pharmaceutical formulations. -
Drug Impurity
Hydrocortisone impurity 1, also known as 6β-Hydroxy cortisol, is a structural impurity derived from Hydrocortisone. This compound is relevant in quality control and analytical studies focused on pharmaceuticals, particularly in the evaluation of drug purity and validation of analytical methods. Its role in understanding the stability and degradation pathways of corticosteroid formulations is crucial for ensuring the safety and efficacy of therapeutic agents. -
Drug Impurity
1-Propyl-1H-pyrazole is identified as a drug impurity with potential implications in pharmacological studies. This compound serves as a reference material for assessing the purity and quality of pyrazole-based therapeutics. Its significance extends to its role in understanding the metabolic byproducts and safety profiles of pyrazole derivatives in drug development. -
Drug Impurity
Sitagliptin impurity 20 is a known impurity associated with the DPP-4 inhibitor Sitagliptin. It is primarily utilized in analytical chemistry for quality control and characterization of pharmaceutical formulations containing Sitagliptin. Researchers employ this impurity to evaluate the purity and stability of Sitagliptin during drug development studies. -
Drug Impurity
Clopidogrel impurity 2 is a key impurity associated with the antiplatelet agent Clopidogrel. It is primarily utilized in pharmaceutical research to evaluate the purity and quality of Clopidogrel formulations. This compound serves as a reference standard in the development of analytical methods for drug testing and in the study of potential degradation pathways. -
Drug Impurity
(rel)-Lopinavir is a notable drug impurity of the antiretroviral agent Lopinavir. It is primarily used for quality control and analytical research in the pharmaceutical industry, facilitating the assessment of drug purity and safety. This compound can provide insights into the metabolism and pharmacokinetics of Lopinavir as well as its potential impurities. -
Drug Impurity
Losartan impurity 17 is a byproduct associated with the synthesis of Losartan, an angiotensin II receptor blocker. This compound is primarily utilized in analytical chemistry and quality control applications to ensure the purity of pharmaceutical formulations containing Losartan. Its identification and quantification are essential for regulatory compliance and safety assessments in drug development. -
Drug Impurity
Prasugrel impurity 2 hydrochloride, also known as Defluoro prasugrel hydrochloride, is a chemical impurity associated with the synthesis of Prasugrel hydrochloride. This compound serves as a critical reference standard for the analysis and characterization of drug purity and stability in pharmaceutical research. It plays a significant role in the development and quality control of antiplatelet therapies, enabling researchers to evaluate the impact of impurities on therapeutic efficacy and safety. -
Drug Impurity
(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Dichloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate, known as Beclometasone Dipropionate Impurity, functions as a chemical impurity in pharmaceutical applications. This compound is primarily studied for its role in the characterization and quality control of beclometasone formulations. It serves as a crucial component for researchers assessing drug purity and stability in corticosteroid therapies. -
Drug Impurity
Candesartan impurity 14 is a chemical byproduct of Candesartan, an angiotensin II receptor blocker (ARB) used primarily for the treatment of hypertension and heart failure. This impurity can serve as an important reference standard in quality control, stability testing, and regulatory compliance during the synthesis of Candesartan. It is useful for researchers focusing on drug development and impurity profiling to ensure the safety and efficacy of pharmaceutical formulations. -
Drug Impurity
Budesonide impurity 88 is a characterized impurity of the corticosteroid Budesonide, primarily associated with its synthesis and formulation. This compound is relevant for research on drug purity and stability testing, as well as compliance with regulatory standards. Its identification and quantification can be important for analytical chemistry applications and the evaluation of pharmaceutical quality. -
Drug Impurity
Brimonidine impurity 8 is a characterized impurity of the alpha-2 adrenergic agonist, Brimonidine. It is primarily utilized in the analysis of pharmaceutical formulations to ensure the quality and safety of the active ingredient. This reagent is essential for researchers conducting studies on drug stability, efficacy, and compliance with regulatory standards. -
Drug Impurity
Glipizide impurity 11 is a characterized impurity of the antidiabetic agent Glipizide. This compound serves as a reference standard for quality control and analytical purposes during the production and testing of Glipizide. Its detection and quantification are essential for ensuring compliance with regulatory standards and maintaining the integrity of pharmaceutical formulations. -
Drug Impurity
Afatinib impurity 90 is a chemical impurity associated with the anti-cancer drug Afatinib, a potent irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity serves as an important reference standard for analytical and quality control processes in the pharmaceutical development of Afatinib. It can be particularly useful for stability studies, impurity profiling, and regulatory compliance assessments in drug manufacturing. -
Drug Impurity
Everolimus impurity 8 is a chemical impurity associated with the mTOR inhibitor Everolimus. Its presence is significant for analytical studies and quality control in pharmaceutical development. This compound serves as a reference standard for assessing the purity and stability of Everolimus formulations in various biological research applications. -
Drug Impurity
Acetazolamide impurity 1 is a known impurity of the carbonic anhydrase inhibitor Acetazolamide. This compound is used primarily in pharmaceutical research to assess the purity and quality of Acetazolamide formulations. It serves as a critical reference standard in the development and validation of analytical methods in drug quality control. -
Drug Impurity
Amoxicillin Impurity 1 is a chemical byproduct associated with the biosynthesis and degradation of Amoxicillin. It serves as an important reference standard in pharmaceutical development and quality control, particularly for ensuring the purity and safety of Amoxicillin formulations. Researchers utilize this impurity to study drug stability and assess potential impacts on efficacy and toxicity. -
Drug Impurity
Ropinirole impurity 3 is a characterized impurity associated with the dopamine receptor agonist Ropinirole. This compound is crucial for assessing the purity and quality of Ropinirole in pharmaceutical formulations. It aids in the development and validation of analytical methods required for regulatory compliance in drug manufacturing. -
Drug Impurity
Clindamycin palmitate impurity 4 (Clindamycin laurate) is a drug impurity associated with the antibiotic clindamycin. This impurity may arise during the manufacturing process and is important for quality control and pharmacological studies. Research applications include the assessment of drug stability, purity, and the evaluation of related substances in pharmaceutical formulations. Understanding such impurities is crucial for ensuring the safety and efficacy of therapeutic agents. -
Drug Impurity
Dabigatran impurity 16 is a known impurity associated with the anticoagulant agent Dabigatran. This compound serves as a crucial reference standard for quality control and analytical testing in the pharmaceutical industry. Its characterization is vital for ensuring the safety and efficacy of Dabigatran formulations in drug development and regulatory compliance. Researchers can utilize this impurity to study its effects on drug stability and purity assessments in various analytical methods. -
Drug Impurity
Tamsulosin impurity 19 is a chemical impurity associated with the synthesis of Tamsulosin, a selective alpha-1 adrenergic antagonist. This impurity serves as a reference standard in quality control and analytical testing, aiding in the identification and characterization of pharmaceuticals. Its presence is crucial for ensuring product purity and compliance with regulatory standards in the pharmaceutical industry. -
Drug Impurity
Haloperidol impurity 6, also known as Haloperidol hydrobromide, is a recognized impurity associated with the antipsychotic medication Haloperidol. This compound can be utilized in the investigation of drug stability, purity assessment, and quality control during pharmaceutical development. Its analysis is critical for ensuring the safety and efficacy of Haloperidol formulations in clinical applications. -
Drug Impurity
Azithromycin impurity 7, also known as Azithromycin F, is a known impurity associated with azithromycin. This compound serves as a reference standard for the identification and quantification of impurities in azithromycin formulations. Its characterization is critical for ensuring the quality and safety of azithromycin as a pharmaceutical agent. Researchers may utilize this reagent in stability studies and quality control analyses to monitor purity levels in drug development processes. -
Lacosamide Impurity
Lacosamide impurity 1 is a significant intermediate in the synthesis of Lacosamide. This impurity is critical for research related to the development and characterization of Lacosamide, a compound used in the treatment of epilepsy. The study of this impurity enhances understanding of Lacosamide's chemical properties and its metabolic pathways. -
Drug Impurity
Itraconazole impurity 2 is a known impurity associated with Itraconazole, a broad-spectrum antifungal agent that targets the lanosterol-14α-demethylase enzyme. This compound can be utilized in drug formulation studies to assess impurity levels, stability, and the overall quality of pharmaceutical products. Its analysis is crucial for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Clenbuterol impurity 1 is a drug impurity associated with the bronchodilator Clenbuterol. This compound is utilized primarily in the evaluation of pharmaceutical formulations and stability studies. Its presence must be assessed to ensure the purity and safety of Clenbuterol in research and clinical applications. -
Drug Impurity
Testosterone Impurity 22 is a recognized impurity of testosterone, primarily associated with the synthesis and analysis of testosterone formulations. This compound serves as a critical reference standard in the quality control and characterization of testosterone products. Its presence and quantification are essential for ensuring the purity and safety of testosterone-based therapeutics in pharmaceutical research. -
Drug Impurity
Clonidine impurity 1 is identified as an impurity related to Clonidine, a centrally acting alpha-2 adrenergic agonist. Its presence in pharmaceutical formulations is critical for quality control and regulatory compliance in drug development. This compound is utilized in analytical research to assess the purity of Clonidine and to ensure safe and effective pharmaceutical products. -
Drug Impurity
Paliperidone impurity 4, also known as 5-Fluoro paliperidone, serves as a drug impurity related to the antipsychotic agent Paliperidone. This compound is often analyzed for its potential impact on drug safety and efficacy. It is important in the context of pharmaceutical development and quality control, providing insights into the stability and integrity of drug formulations. -
Drug Impurity
Itraconazole impurity 8, also referred to as Itraconazole impurity C, serves as a specific impurity of the antifungal agent Itraconazole. Its characterization is essential for quality control and chemical analysis in the pharmaceutical development of Itraconazole. This compound can be utilized in research applications focusing on drug formulation safety and efficacy, as well as in studies evaluating the pharmacokinetics and stability of antifungal medications. -
Drug Impurity
Cetirizine impurity 3 is a known impurity of the antihistamine cetirizine, primarily characterized as a byproduct in the synthesis process. This compound plays a crucial role in the quality control and analytical assessment of cetirizine formulations. It is utilized in pharmaceutical research to ensure the purity and safety of cetirizine products as well as in stability testing to comply with regulatory standards. -
Drug Impurity
Apixaban impurity 50 is a characterized impurity associated with the anticoagulant Apixaban. This compound is relevant for quality control and analytical studies concerning the safety and efficacy of Apixaban formulations. Researchers can utilize Apixaban impurity 50 to investigate the stability, degradation pathways, and potential therapeutic implications of the primary drug component. -
Drug Impurity
Losartan impurity 8 (O-Acetyl Losartan) is a known impurity of the antihypertensive agent Losartan. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. This compound is significant for ensuring the purity and regulatory compliance of Losartan formulations. Its characterization aids in understanding the pharmacological profile and potential impacts of impurities on drug efficacy and safety. -
Drug Impurity
Sildenafil impurity 12 is a chemical impurity associated with the synthesis of Sildenafil. This compound is primarily utilized in analytical research to assess the purity of pharmaceutical formulations. Its presence can impact the overall quality and efficacy of Sildenafil-related products, making it essential for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Donepezil impurity 5 hydrochloride, also known as Deoxydonepezil hydrochloride, is a chemical impurity associated with Donepezil hydrochloride. This compound is crucial for analytical studies and quality control assessments in pharmaceutical research, particularly in the evaluation of drug purity and stability. Its characterization aids in understanding the product's safety and efficacy profiles. -
Coclaurine Impurity
N-Methyl-3'-hydroxycoclaurine hydrochloride is an impurity of coclaurine, primarily acting as a reference substance in analytical studies. It is utilized in research applications involving the characterization and quantification of coclaurine in botanical extracts. This compound contributes to the understanding of the biosynthesis and metabolic pathways of alkaloids in plant studies. -
Drug Impurity
Rosuvastatin impurity 8 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound serves as a reference standard for quality control and characterization in pharmaceutical development. Its evaluation is critical for ensuring the purity and safety of Rosuvastatin formulations in research and industrial applications. -
Drug Impurity
Apixaban impurity 16 is a chemical impurity associated with Apixaban, a direct oral anticoagulant that selectively inhibits Factor Xa. This impurity is critical for pharmaceutical quality control and analytical studies focused on the characterization of Apixaban formulations. Its presence can impact the safety and efficacy profile of Apixaban, making it relevant for regimens evaluating drug stability and metabolic pathways. -
Drug Impurity
Tamsulosin impurity 14 is a known impurity associated with the pharmaceutical compound Tamsulosin, primarily targeting alpha-1 adrenergic receptors. This impurity is significant for quality control and analytical studies in drug development, particularly in determining the purity and stability of Tamsulosin formulations. Its characterization is essential for compliance with pharmaceutical regulations and ensuring therapeutic efficacy. -
Drug Impurity
Metoprolol impurity 1, also known as ortho-Metoprolol, is a recognized impurity associated with the pharmaceutical compound Metoprolol. This compound is primarily utilized in the assessment of drug purity and stability for quality control in pharmaceutical formulations. Research applications include analytical chemistry and regulatory studies to ensure compliance with safety and efficacy standards in drug development.
